Philip J. M. van Galen

Statistics

Publications

Citations

695

H-Index

Active since

1987

Affiliations

National Institute of Diabetes and Digestive and Kidney Diseases(Current)

National Institutes of Health

Duke Medical Center

SNV Netherlands Development Organisation

Philip J. M. van Galen is an author at National Institute of Diabetes and Digestive and Kidney Diseases specializing in pharmacology, molecular pharmacology, and ligand binding.

Publications per year

1987–1999

Publications

Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists

Kenneth A. Jacobson, Carola Gallo‐Rodriguez, Neli Melman et al. · Journal of Medicinal Chemistry · 1993 · 150 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

1H-Imidazo[4,5-c]quinolin-4-amines: novel non-xanthine adenosine antagonists

Philip J. M. van Galen, P.J.A. Nissen, I. van Wijngaarden et al. · Journal of Medicinal Chemistry · 1991 · 63 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

1-Aminoisoquinoline as benzamidine isoster in the design and synthesis of orally active thrombin inhibitors

J. B. M. Rewinkel, Hans Lucas, Philip J. M. van Galen et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 56 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Influence of the molecular structure of N6-(ω-aminoalkyl)adenosines on adenosine receptor affinity and intrinsic activity

Adriaan P. IJzerman, Philip J. M. van Galen, W. Soudijn · European Journal of Pharmacology Molecular Pharmacology · 1989 · 51 citations

Medicine, Medicinal Chemistry, Pharmacology +12

A model for the antagonist binding site on the adenosine A1 receptor, based on steric, electrostatic, and hydrophobic properties

Philip J. M. van Galen, Herman van Vlijmen, Adriaan P. IJzerman et al. · Journal of Medicinal Chemistry · 1990 · 47 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1–5 of 16